Literature DB >> 16127746

Novel rapid tissue lysis method to evaluate cancer proteins: correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation.

Wei-Shone Chen1, Hong-Yi Chang, Jui-Ting Chang, Jacqueline Ming Liu, Chung-Pin Li, Li-Li Chen, Huei-Ling Chang, Chia-Chi Chen, Tze-Sing Huang.   

Abstract

AIM: We optimized a rapid and efficient tissue lysis method using the MagNA Lyser (Roche, Germany). Using this novel method combined with immunoblot analysis, we investigated the correlation between abnormal Bcl-X(L) expression and clinicopathological characteristics in colorectal cancer.
METHODS: Tissue samples from Sprague-Dawley rats were tested to determine optimal lysis conditions for use with MagNA Lyser. We next used the new method to extract tissue proteins from the tumor tissue of a colorectal cancer patient. The availability of extractable tissue proteins for proteomic study was demonstrated by two-dimensional (2D) gel electrophoresis and subsequent matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. In addition, we prepared tissue lysates from paired tumor tissues and adjacent nontumor tissues of 50 colorectal carcinoma patients. Ensuing immunoblot analyses were performed to detect the level of Bcl-X(L) expression.
RESULTS: The optimal sample sizes processed were found to be around 200 mg, with oscillation frequency of 6500 r/min for 80 s. Test of the first human tissue lysate confirmed that the MagNA Lyser method was adequate for protein extraction and subsequent identification by current proteomic protocols. The method was also applicable to immunoblot analysis. Thirty of 50 (60%) colorectal patients exhibited higher level of Bcl-X(L) expression in their tumor tissues. Raised level of Bcl-X(L) expression correlated with patients' gender and tumor cell proliferation index (P = 0.037 and P<0.001, respectively), but was independent of clinicopathological characteristics and overall survival.
CONCLUSION: We report a novel tissue lysis method applicable to proteomic and immunoblot analyses, which can facilitate the discovery and detection of cancer protein alterations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127746      PMCID: PMC4320389          DOI: 10.3748/wjg.v11.i33.5162

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.

Authors:  Z Xu; H Friess; M Solioz; S Aebi; M Korc; J Kleeff; M W Büchler
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Authors:  M Krajewska; S F Moss; S Krajewski; K Song; P R Holt; J C Reed
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

3.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

Authors:  C J Pike
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

Review 4.  Apoptosome dysfunction in human cancer.

Authors:  K M Hajra; J R Liu
Journal:  Apoptosis       Date:  2004-11       Impact factor: 4.677

Review 5.  Exploiting death receptor signaling pathways for tumor therapy.

Authors:  Simone Fulda; Klaus-Michael Debatin
Journal:  Biochim Biophys Acta       Date:  2004-12-10

6.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

7.  Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.

Authors:  E Ogura; H Senzaki; D Yamamoto; R Yoshida; H Takada; K Hioki; A Tsubura
Journal:  Oncol Rep       Date:  1999 Mar-Apr       Impact factor: 3.906

8.  Butyrate and aspirin in combination have an enhanced effect on apoptosis in human colorectal cancer cells.

Authors:  T Menzel; J Schauber; F Kreth; T Kudlich; R Melcher; A Gostner; W Scheppach; H Lührs
Journal:  Eur J Cancer Prev       Date:  2002-06       Impact factor: 2.497

9.  Participation of cyclin A in Myc-induced apoptosis.

Authors:  A T Hoang; K J Cohen; J F Barrett; D A Bergstrom; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin.

Authors:  Theocharis Panaretakis; Katja Pokrovskaja; Maria C Shoshan; Dan Grandér
Journal:  J Biol Chem       Date:  2002-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.